Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Clague Laura
Relationship:   Director
City:   San Diego
State:   CA
   
Insider Summary:
  
   
Companies Owned :   3    
Direct Shares   424,757    

Indirect Shares

   2,000      
Direct Value   $1,041,888    

Indirect Value

   $3,640      
Total Shares   426,757      
Total Value   $1,045,528      


Genasys Inc $517,446 Travere Therapeutics, Inc $264,560 Fluidigm Corp $259,882 Genasys Inc $517,446 Travere Therapeutics, Inc $264,560 Fluidigm Corp $259,882
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    3    

     Stock price went up :
    0   
    1    
     Stock price went down :
    0   
    2    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
 -32.4%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Genasys Inc GNSS Director 2022-04-27 284,311 2022-04-27 2,000    Premium*  
            Travere Therapeutics, Inc TVTX Chief Financial Officer 2022-05-11 35,655 2018-02-08 0    Premium*  
            Fluidigm Corp FLDM Director 2023-06-14 104,791 2018-10-30 0    Premium*  
* Premium Members only  

Records found :    65         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 3
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
FLDM Fluidigm Corp Director   –       •      –    2023-06-14 4 A $0.00 $0 D/D 26,376 104,791 0 -
TVTX Travere Therapeutics, Inc Chief Financial Officer   •       –      –    2018-11-14 4 AS $23.63 $88,970 D/D (3,750) 15,783 0 -
TVTX Travere Therapeutics, Inc Chief Financial Officer   •       –      –    2018-11-15 4 AS $24.20 $91,167 D/D (3,750) 12,033 0 -
TVTX Travere Therapeutics, Inc Chief Financial Officer   •       –      –    2018-12-20 4 AS $22.08 $82,805 D/D (3,750) 15,783 0 -
TVTX Travere Therapeutics, Inc Chief Financial Officer   •       –      –    2018-12-21 4 AS $21.67 $81,860 D/D (3,750) 12,033 0 -
TVTX Travere Therapeutics, Inc Chief Financial Officer   •       –      –    2019-02-11 4 AS $21.38 $21,743 D/D (1,017) 11,016 0 -
TVTX Travere Therapeutics, Inc Chief Financial Officer   •       –      –    2019-02-12 4 AS $21.50 $21,844 D/D (1,016) 10,000 0 -
TVTX Travere Therapeutics, Inc Chief Financial Officer   •       –      –    2019-05-15 4 AS $17.78 $22,225 D/D (1,250) 14,750 0 -
TVTX Travere Therapeutics, Inc Chief Financial Officer   •       –      –    2019-05-16 4 AS $18.71 $23,388 D/D (1,250) 13,500 0 -
TVTX Travere Therapeutics, Inc Chief Financial Officer   •       –      –    2020-03-10 4 AS $15.02 $60,080 D/D (4,000) 22,500 0 %
TVTX Travere Therapeutics, Inc Chief Financial Officer   •       –      –    2020-05-11 4 AS $14.95 $18,688 D/D (1,250) 21,250 0 %
TVTX Travere Therapeutics, Inc Chief Financial Officer   •       –      –    2020-05-12 4 AS $16.98 $30,401 D/D (1,777) 19,473 0 %
TVTX Travere Therapeutics, Inc Chief Financial Officer   •       –      –    2020-09-22 4 AS $18.59 $27,885 D/D (1,500) 20,973 0 %
TVTX Travere Therapeutics, Inc Chief Financial Officer   •       –      –    2020-09-23 4 AS $18.48 $27,720 D/D (1,500) 19,473 0 %
TVTX Travere Therapeutics, Inc Chief Financial Officer   •       –      –    2020-11-13 4 AS $23.61 $177,071 D/D (7,500) 26,973 0 %
TVTX Travere Therapeutics, Inc Chief Financial Officer   •       –      –    2020-11-16 4 AS $23.98 $179,813 D/D (7,500) 19,473 0 %
TVTX Travere Therapeutics, Inc Chief Financial Officer   •       –      –    2020-11-24 4 AS $23.86 $89,475 D/D (3,750) 23,223 0 %
TVTX Travere Therapeutics, Inc Chief Financial Officer   •       –      –    2020-11-25 4 AS $22.72 $85,200 D/D (3,750) 19,473 0 %
TVTX Travere Therapeutics, Inc Chief Financial Officer   •       –      –    2021-02-02 4 AS $30.75 $111,469 D/D (3,625) 35,848 0 %
TVTX Travere Therapeutics, Inc Chief Financial Officer   •       –      –    2021-02-03 4 AS $28.91 $104,799 D/D (3,625) 32,223 0 %
TVTX Travere Therapeutics, Inc Chief Financial Officer   •       –      –    2021-02-05 4 AS $31.41 $70,673 D/D (2,250) 34,473 0 %
TVTX Travere Therapeutics, Inc Chief Financial Officer   •       –      –    2021-02-08 4 AS $31.58 $71,055 D/D (2,250) 32,223 0 %
TVTX Travere Therapeutics, Inc Chief Financial Officer   •       –      –    2021-05-11 4 AS $19.14 $38,280 D/D (2,000) 30,223 0 %
TVTX Travere Therapeutics, Inc Chief Financial Officer   •       –      –    2021-05-12 4 AS $19.46 $38,920 D/D (2,000) 28,223 0 %
TVTX Travere Therapeutics, Inc Chief Financial Officer   •       –      –    2022-01-11 4 AS $27.40 $205,500 D/D (7,500) 31,316 0 %
  65  Records found
  1   2  3      
  Page 2 of 3  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us